Dyslipidemia in women with polycystic ovary syndrome
Dyslipidemia is a very common metabolic abnormality in women with polycystic ovary syndrome (PCOS). Insulin resistance is a key pathophysiology of PCOS, thus dyslipidemia in women with PCOS may be consistent with those found in an insulin resistant state. In recent meta-analysis, triglycerides and l...
Main Authors: | Kim, Jin Ju, Choi, Young Min |
---|---|
Format: | Online |
Language: | English |
Published: |
Korean Society of Obstetrics and Gynecology; Korean Society of Contraception and Reproductive Health; Korean Society of Gynecologic Endocrinology; Korean Society of Gynecologic Endoscopy and Minimal Invasive Surgery; Korean Society of Maternal Fetal Medicine; Korean Society of Ultrasound in Obstetrics and Gynecology
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3784112/ |
Similar Items
-
Vitamin D deficiency in women with polycystic ovary syndrome
by: Kim, Jin Ju, et al.
Published: (2014) -
Adiponectin in Women with Polycystic Ovary Syndrome
by: Shin, Hyun-Young, et al.
Published: (2011) -
Effects of insulin-sensitizing agents and insulin resistance in women with polycystic ovary syndrome
by: Hwang, Kyu Ri, et al.
Published: (2013) -
Predictors of Subclinical Cardiovascular Disease in Women with Polycystic Ovary Syndrome: Interrelationship of Dyslipidemia and Arterial Blood Pressure
by: Macut, Djuro, et al.
Published: (2015) -
Clinical characteristics of polycystic ovary syndrome in Indian women
by: Ramanand, Sunita J., et al.
Published: (2013)